Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Saturday
May 07
16:55 - 17:55
Poster Station 2
08: Advances in radiotherapy planning & techniques
Madalyne Day, Switzerland
1600
Poster Discussion
RTT
AI-based OAR annotation for pediatric brain radiotherapy planning
Thais Roque, France
PD-0330

Abstract

AI-based OAR annotation for pediatric brain radiotherapy planning
Authors:

Pierre-Yves Bondiau1, Stephanie Bolle2, Alexandre Escande3,4,5, Loig Duverge6, Charlotte Demoor7,8, Angela Rouyar-Nicolas2, Basile Bertrand9, Arthus Cannard9, Leo Hardy9, Catherine Martineau-Huynh10, Nikos Paragios9,11, Thais Roque10, Eric Deutsch2, Charlotte Robert2

1IMPT, Centre Antoine Lacassagne, Radiation Oncology , Nice, France; 2Gustave Roussy Cancer Campus, Department of Radiation Oncology, Villejuif, France; 3Oscar Lambret Comprehensive Cancer Center, Department of Radiation Oncology, Lille, France; 4H.Warembourg School of medicine, University of Lille, School of Medicine, Lille, France; 5University of Lille, CRIStAL Laboratory, UMR 9189,, Lille, France; 6Eugène Marquis Comprehensive Cancer Center, Department of Radiation Oncology, Rennes, France; 7Centre François Baclesse, Radiotherapy department, Caen, France; 8CHU Angers, Pediatric Oncology, Angers, France; 9TheraPanacea, Research and Development, Paris, France; 10TheraPanacea, Clinical and Partnerships Affairs, Paris, France; 11CentraleSupelec, University of Paris-Saclay, Computer Science and Applied Mathematics, Gif-sur-Yvette, France

Show Affiliations
Purpose or Objective

Pediatric central nervous system (CNS) tumors, the second most common childhood malignancy and the most common solid tumor in children, comprise tumors of the brain, the spinal cord, and the meninges. The management of brain tumors depends on patient age, histology, tumor location and extent but typically involves a radiation therapy (RT) planning based on computed tomography (CT) and magnetic resonance imaging (MRI). MRI is acquired for detailed tumor localization and delineations of the target and OARs thanks to its excellent soft-tissue contrast. Contouring, especially for pediatric cases, suffers from inter/intra expert variability while being time consuming. In this study, a commercial solution for automatic OAR delineation, previously trained and validated on adult patients, was tested on an unseen cohort of pediatric patients to evaluate its clinical acceptability.

Material and Methods

ART-Net, a CE-marked, FDA-cleared anatomically preserving deep-learning ensemble architecture for automatic annotation of OAR was evaluated using pediatric patients from 2 centers selected across 4 different age groups 0-2y (9), 2-5y (10), 5-10y (10) and 10-15y (10). For each patient, automatic contours (AC) of 24 OARs were performed and submitted to 5 experts across 4 centers for evaluation. Contours were scored as A/acceptable, B/ acceptable after minor corrections, and C/ not acceptable for clinical use. To avoid any bias, experts were blind to the fact that all contours were generated automatically.

Results

AC were generated in a mean time of 0.5s per scan slice. 90.54% of structures were considered clinically acceptable (scored as A or B) across all ages. In 3% of the cases, the algorithm failed to recognize structures such as vestibular and semicircular canals (VSCC) and cochlea, for which T1w is not the reference sequence. Across all ages and organs, the 5 experts agreed on 44% of all contours, hinting on the intervariability of the contouring practice. Table 1 shows how the performance of the software increases with age group: age groups of 5-10y and 10-15y show higher clinical acceptability (93.17% and 91.25%) than groups 0-2y and 2-5y (88.72% and 88.83%). Only 2.76% of the structures were scored as a C, with the least performing organs being brainstem and anterior cerebellum, especially for the youngest age groups of 0-2y and 2-5y (17.89% and 22.00%), especially due to the presence of tumors in the posterior fossa which deformed these OARs and led to impossibility of distinguishing between tumor and healthy tissue.



Conclusion

We show first results for the evaluation of MR-brain AI-based auto-contouring for pediatric cases. The results show very good acceptance, highlighting the high usability of the commercial tool for MR annotation for pediatric brain cases and its clinical implementation feasibility. In the future, a comparison between AI and human expert and a dosimetric evaluation will be performed.